Join
Live feed
·
INSIDERFilingvia Quantisnow
Phathom Pharmaceuticals Inc. logo

Principal Accounting Officer Breedlove Robert Charles covered exercise/tax liability with 460 shares, decreasing direct ownership by 0.77% to 59,465 units (SEC Form 4) to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHAT (Phathom Pharmaceuticals Inc.) and more on Quantisnow.